Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

PBE vs. IBBQ: which is better?

Bottom line

PBE vs IBBQ: the short answer

PBE (Invesco Biotechnology & Genome ETF) and IBBQ (Invesco Nasdaq Biotechnology ETF) share a meaningful slice of their top holdings — about 56% by weight.

But IBBQ is far broader, holding 261 positions to 33 for PBE, so beyond the top names it adds exposure PBE doesn't have.

IBBQ is cheaper at 0.19% vs 0.59% — a difference of $40 a year per $10,000 invested.

Over one year, PBE returned +24.7% vs −0.6% for IBBQ (reporting dates differ).

Updated Nov 19, 2026

PBE vs IBBQ side by side

PBEIBBQ
TypeETFETF
Fund familyInvescoInvesco
CategoryTechnology SectorTechnology Sector
Expense ratio0.59%0.19%
Annual cost per $10k$59$19
10-yr cost on $10k (prospectus)$738$242
Max front loadNoneNone
12b-1 fee——
1-yr return+24.7%−0.6%
5-yr return (annualized)+3.4%—
10-yr return (annualized)+5.2%—
Best quarter+25.3%+12.0%
Worst quarter−24.3%−11.7%
Net assets (fund)$281.9M$67.4M
Number of holdings33261
Portfolio turnover103%17%
Returns as ofDec 31, 2025Dec 31, 2024

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearPBEIBBQDifference
2024+1.1%−0.6%+1.7%
2023+3.7%+4.5%−0.8%
2022−10.8%−10.2%−0.5%

Source: Fund prospectus bar charts

Holdings overlap

14 of PBE's top 25 holdings also appear in IBBQ's top 25.

Shared top holdings
HoldingPBEIBBQ
Invesco Private Prime Fund12.89%14.20%
Regeneron Pharmaceuticals, Inc.5.47%5.08%
Amgen Inc.5.22%7.10%
Vertex Pharmaceuticals Inc.4.99%7.38%
Invesco Private Government Fund4.97%5.48%
Royalty Pharma PLC4.94%1.90%
Biogen Inc.4.79%2.29%
Gilead Sciences, Inc.4.43%7.39%
United Therapeutics Corp.4.08%1.94%
Illumina, Inc.3.51%1.98%
Alnylam Pharmaceuticals, Inc.3.17%3.19%
Incyte Corp.3.06%1.53%
Neurocrine Biosciences, Inc.2.66%1.26%
Exelixis, Inc.2.64%1.04%

Source: SEC Form N-PORT

PBE top 10

  1. Invesco Private Prime Fund — 12.89%
  2. Regeneron Pharmaceuticals, Inc. — 5.47%
  3. Amgen Inc. — 5.22%
  4. CareDx, Inc. — 5.04%
  5. Vertex Pharmaceuticals Inc. — 4.99%
  6. Invesco Private Government Fund — 4.97%
  7. Royalty Pharma PLC — 4.94%
  8. Biogen Inc. — 4.79%
  9. Gilead Sciences, Inc. — 4.43%
  10. United Therapeutics Corp. — 4.08%

IBBQ top 10

  1. Invesco Private Prime Fund — 14.20%
  2. Gilead Sciences, Inc. — 7.39%
  3. Vertex Pharmaceuticals Inc. — 7.38%
  4. Amgen Inc. — 7.10%
  5. Invesco Private Government Fund — 5.48%
  6. Regeneron Pharmaceuticals, Inc. — 5.08%
  7. Alnylam Pharmaceuticals, Inc. — 3.19%
  8. Revolution Medicines, Inc. — 2.48%
  9. Biogen Inc. — 2.29%
  10. Illumina, Inc. — 1.98%

FAQ

What is the difference between PBE and IBBQ?
PBE (Invesco Biotechnology & Genome ETF) and IBBQ (Invesco Nasdaq Biotechnology ETF) share a meaningful slice of their top holdings — about 56% by weight. But IBBQ is far broader, holding 261 positions to 33 for PBE, so beyond the top names it adds exposure PBE doesn't have.
Which is cheaper, PBE or IBBQ?
IBBQ has the lower expense ratio (0.19%).
Should I own both PBE and IBBQ?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.